Clinical Trial Update: Efficacy and Safety of Two Different Botulinum Toxin Type A Treatments for Moderate to Severe Cervical Dystonia [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing two botulinum toxin type A treatments for moderate to severe cervical dystonia was terminated, with results posted in 2011.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cervical Dystonia

Drugs mentioned

• Botulinum toxin type A - formulation 1 (botulinum toxin type A)
• Botulinum toxin type A - formulation 2 (botulinum toxin type A)

Snippet

Sponsor: Allergan | Conditions: Spasmodic Torticollis | Phase 4 | Status: TERMINATED | Results posted: 2011-12-16